Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Muluken Altaye Ayza, Kaleab Alemayehu Zewdie, Bekalu Amare Tesfaye, Selamawit Tesfamariam Gebrekirstos & Derbew Fikadu Berhe. (2020) Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity. Diabetes, Metabolic Syndrome and Obesity 13, pages 3627-3635.
Read now
Read now
Yuwen Cai, Weinan Shi & Gaosi Xu. (2020) The efficacy and safety of SGLT2 inhibitors combined with ACEI/ARBs in the treatment of type 2 diabetes mellitus: A meta-analysis of randomized controlled studies. Expert Opinion on Drug Safety 19:11, pages 1497-1504.
Read now
Read now
Articles from other publishers (13)
Motonobu Nakamura, Nobuhiko Satoh, Shoko Horita & Masaomi Nangaku. (2022) Insulin-induced mTOR signaling and gluconeogenesis in renal proximal tubules: A mini-review of current evidence and therapeutic potential. Frontiers in Pharmacology 13.
Crossref
Crossref
Susumu Ogawa, Yusuke Ohsaki, Manami Shimizu, Kazuhiro Nako, Masashi Okamura, Shigeru Kabayama, Kiyoshi Tabata, Yasuhisa Tanaka & Sadayoshi Ito. (2021) Electrolyzed hydrogen-rich water for oxidative stress suppression and improvement of insulin resistance: a multicenter prospective double-blind randomized control trial. Diabetology International 13:1, pages 209-219.
Crossref
Crossref
Rajni Sharma & Swasti Tiwari. (2021) Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes. World Journal of Diabetes 12:5, pages 556-568.
Crossref
Crossref
Xiaoya Sun, Ziqiang Cao, Yuanyuan Ma, Yimin Shao, Junqing Zhang, Geheng Yuan & Xiaohui Guo. (2021)
Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
via
activating the PI3K/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes
. Food & Function 12:3, pages 1207-1218.
Crossref
Crossref
Jun Hirao, Akihiro Tojo, Saaya Hatakeyama, Hiroshi Satonaka & Toshihiko Ishimitsu. (2020) V-ATPase blockade reduces renal gluconeogenesis and improves insulin secretion in type 2 diabetic rats. Hypertension Research 43:10, pages 1079-1088.
Crossref
Crossref
Yuwen Cai, Xin Liu & Gaosi Xu. (2020) Combination therapy with SGLT2 inhibitors for diabetic kidney disease. Biomedicine & Pharmacotherapy 127, pages 110192.
Crossref
Crossref
Ele Ferrannini, Ricardo Pereira-Moreira, Marta Seghieri, Eleni Rebelos, Aglécio L Souza, Valeria B Chueire, Caterina Arvia & Elza Muscelli. (2020) Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport. BMJ Open Diabetes Research & Care 8:1, pages e001178.
Crossref
Crossref
Ricardo Pereira-Moreira & Elza Muscelli. (2020) Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review. Journal of Diabetes Research 2020, pages 1-17.
Crossref
Crossref
Myat Theingi Swe, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Nipon Chattipakorn & Anusorn Lungkaphin. (2018) Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions. Journal of Cellular Physiology 234:6, pages 8134-8151.
Crossref
Crossref
Akihiro Tojo, Saaya Hatakeyama, Masaomi Nangaku & Toshihiko Ishimitsu. (2018) H+-ATPase blockade reduced renal gluconeogenesis and plasma glucose in a diabetic rat model. Medical Molecular Morphology 51:2, pages 89-95.
Crossref
Crossref
Anton Ivanovich Korbut & Vadim Valer'evich Klimontov. (2017) Empagliflozin: a new strategy for nephroprotection in diabetes. Diabetes mellitus 20:1, pages 75-84.
Crossref
Crossref
Gaurav Pandey, Kripa Shankar, Ekta Makhija, Anil Gaikwad, Carolyn Ecelbarger, Anil Mandhani, Aneesh Srivastava & Swasti Tiwari. (2017) Reduced Insulin Receptor Expression Enhances Proximal Tubule Gluconeogenesis. Journal of Cellular Biochemistry 118:2, pages 276-285.
Crossref
Crossref
Martin C. Michel, Hans R. Brunner, Carolyn Foster & Yong Huo. (2016) Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease. Pharmacology & Therapeutics 164, pages 1-81.
Crossref
Crossref